EYLENBOSCH HILDE 4/A
4/A · ALERE INC. · Filed Mar 1, 2011
Insider Transaction Report
Form 4/AAmended
ALERE INC.ALR
EYLENBOSCH HILDE
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2011-01-19−1,200→ 0 totalExercise: $14.92From: 2001-11-21Exp: 2011-02-12→ Common Stock (1,200 underlying) - Exercise/Conversion
Common Stock
2011-01-19$14.92/sh+1,200$17,904→ 2,800 total
Holdings
- 39,143(indirect: By Spouse)
Common Stock
- 3,248
Common Stock
Footnotes (5)
- [F1]This option was acquired through a restructuring transaction undertaken by the Issuer's former parent, Inverness Medical Technology, Inc. in connection with the consummation of the transactions contemplated by the agreement and plan of split-off and merger dated as of May 23, 2001 among Johnson & Johnson, Sunrise Acquisition Corp. and Inverness Medical Technology, Inc.
- [F2]This derivative security does not have a price.
- [F3]The reporting person disclaims beneficial ownership of the reported securities.
- [F4]This form has been amended (a) to correct an error in the aggregate number of shares directly owned by the reporting person following the transaction, (b) to include shares jointly owned by the reporting person which were unintentionally omitted, and (c) correct the aggregate number of shares owned by the spouse of the reporting person for shares acquired through cash exercises of stock options in 2005 and 2008 that were not previously reported.
- [F5]These securities are jointly owned with the reporting person's spouse.